Vaginitis and Vaginal Flora: What Is Normal and When to Seek Care
Key Takeaways
In many women of reproductive age, protective bacteria called lactobacilli help keep the vagina acidic. Vaginitis is a group of symptoms, such as discharge, odour, itching, or pain. It can come from bacterial vaginosis (BV), a yeast infection, trichomoniasis, irritation, or low oestrogen. These symptoms often look alike, so a history, an examination, and the right tests are more reliable than guessing. Gardnerella on a swab is not an automatic reason for antibiotics: the decision depends on symptoms and clinical criteria.
Key evidence: CDC STI Treatment Guidelines: Bacterial Vaginosis ACOG Practice Bulletin No. 215: Vaginitis in Nonpregnant Patients Liu et al. 2025 — bacterial vaginosis and microbial dysbiosis review
The vagina hosts a changing community of microbes: the vaginal flora, or microbiota. In many women of reproductive age, lactobacilli help keep the vagina acidic. Other patterns of flora can also appear without symptoms, so a lab report is not enough to call one “healthy” or “unhealthy”.
A shift in those microbes, an infection, irritation, or low oestrogen can change discharge or cause itching, odour, or burning. Knowing that these symptoms have different causes is the first step in avoiding unnecessary treatment.
What normal vaginal flora does
A lactobacillus-rich flora may include species such as Lactobacillus crispatus, L. jensenii, and L. gasseri. They help produce lactic acid and keep vaginal pH acidic: in women of reproductive age, pH is usually 4.5 or lower (CDC candidiasis guidance).
A flora like this can help:
- Limit some anaerobic bacteria (bacteria that grow without oxygen) linked to bacterial vaginosis
- Produce by-products and germ-fighting substances that shape the mix of microbes
- Support the vaginal lining (mucosa)
The picture is not fixed. It shifts across the menstrual cycle, in pregnancy, after sex, during antibiotic use, and after menopause as oestrogen levels change.

What vaginitis means: signs and symptoms
Vaginitis is an umbrella term for vaginal inflammation or infection. It is not one disease but a clinical picture that can have several distinct causes (ACOG Practice Bulletin No. 215).
People often notice:
- A change in the colour, amount, or texture of vaginal discharge
- Lasting vulvar or vaginal itching, burning, soreness, or redness
- An unpleasant or fishy odour
- Discomfort or sharp pain during sex (dyspareunia)
- Burning when passing urine (dysuria), often where urine touches irritated vulvar skin
Because different conditions can feel very similar, symptoms often cannot identify the cause. That takes a careful history and the right tests.
Common causes: from dysbiosis to infections
An assessment usually looks for these patterns:
Bacterial vaginosis (BV) is the most common cause of vaginal discharge in women of reproductive age. It is a dysbiosis, an imbalance in the vaginal bacteria, rather than an infection with one outside germ. Protective lactobacilli fall, and a mix of anaerobes (Gardnerella vaginalis, Atopobium vaginae, Prevotella) multiplies. Typical clues are thin, watery, greyish-white discharge, a distinct fishy odour, and vaginal pH above 4.5.
Vulvovaginal candidiasis (yeast infection) is an overgrowth of Candida fungi, most often Candida albicans. It usually brings intense vulvar itching, burning, redness, and thick white discharge that can look like cottage cheese. In uncomplicated cases the vaginal pH stays normal (≤ 4.5), a useful contrast with BV.
Trichomoniasis is a common sexually transmitted infection (STI) caused by the single-celled parasite Trichomonas vaginalis. Symptoms can range from mild irritation to heavy, frothy, yellow-green discharge, a strong odour, vulvar swelling, and tiny bleeding points on the cervix (“strawberry cervix”). Vaginal pH is usually elevated (above 4.5).
Genitourinary syndrome of menopause (atrophic vaginitis) develops when oestrogen drops, most often after menopause but also during prolonged breastfeeding or anti-oestrogenic therapy. The vaginal lining thins, glycogen (a stored sugar) falls, lactobacilli decline, and pH rises. Dryness, irritation, and discomfort can follow without an active infection.
Non-infectious contact dermatitis or irritation can mimic an infection. Scented washes, douches, latex condoms, lubricants, or laundry detergents can cause burning and redness even when swabs and cultures are clear.
For a side-by-side look at the two most common patterns, see discharge, itching, or odour: yeast infection or bacterial vaginosis?
Why testing matters before treatment
It is understandable to reach for an over-the-counter antifungal when itching starts. But if the cause is BV, trichomoniasis, or irritation, that product will not fix it and may delay the right assessment.
A clinic assessment combines the history and examination with one or more tests. No single finding settles every case (CDC vaginal discharge guidance):
- Vaginal pH testing. A pH above 4.5 is common with BV or trichomoniasis, while uncomplicated candidiasis usually comes with a normal pH. The pH is a clue rather than a diagnosis: trichomoniasis can also occur with a normal pH.
- Wet mount microscopy. Looking at a fresh sample under the microscope may show clue cells (vaginal cells coated with bacteria), yeast forms, or moving trichomonads. A negative result does not rule out yeast or trichomoniasis, because microscopy can miss many cases.
- Whiff test. A drop of 10% potassium hydroxide (KOH) can release a sharp fishy odour in BV.
- Validated molecular testing. Nucleic acid amplification tests (NAATs) can help detect Trichomonas, identify Candida species, or assess BV-associated bacterial patterns when indicated. BV NAATs are meant for women with symptoms; detecting an organism does not always explain them.
What a “shift in flora” or a Gardnerella result really means
“Shift in vaginal flora” or “Gardnerella vaginalis detected” on a report can be worrying. Neither phrase is a diagnosis by itself.
A positive Gardnerella culture or molecular result is not the same as bacterial vaginosis. The organism can be detected without symptoms. The US CDC does not recommend G. vaginalis culture as a diagnostic test because it is not specific. BV molecular tests should be used only for women with symptoms (CDC bacterial vaginosis guidance).
BV can be diagnosed with at least three of the four Amsel criteria: homogeneous thin discharge, vaginal pH above 4.5, a positive whiff test, and clue cells on microscopy. A Nugent score of 7 to 10 on a Gram-stained smear (a stained sample read under the microscope) can also make the diagnosis (CDC BV guidance).
Dr. Aksoy’s clinical perspective: A laboratory report helps with diagnosis; it does not prescribe the treatment. If a patient has no symptoms and the examination does not support infection, an isolated organism name may not need antibiotics. The result has to be interpreted with the clinical picture. We treat the patient in front of us, not the paper report.
Do sexual partners require treatment?
Partner care follows the confirmed diagnosis:
- Trichomoniasis. Current sexual partners need treatment at the same time, and sex should wait until everyone being treated has finished therapy and symptoms have resolved (CDC trichomoniasis guidance).
- Uncomplicated yeast infections. Routine partner treatment is not indicated, because candidiasis is not considered a sexually transmitted infection.
- Bacterial vaginosis. CDC’s 2021 guidance, still its current version, does not recommend routine partner treatment (CDC BV guidance). In a 2025 randomised trial (participants assigned by chance to different treatment arms) of monogamous heterosexual couples, recurrence within 12 weeks was 35% when the male partner received oral and topical treatment at the same time and 63% when he did not (Vodstrcil et al. 2025). ACOG’s 2025 update says this should be considered for male partners of adults with recurrent, symptomatic BV (ACOG 2025), and ISSVD’s 2026 update endorses selective treatment after a confirmed diagnosis (ISSVD 2026). Pooled analyses published in 2026 reached different conclusions (Aliyu Attahir et al. 2026; Gardella et al. 2026). Partner treatment is therefore a clinician-led option for selected recurrent cases, not a step to start independently.
Treatment depends on the confirmed cause
The plan follows the confirmed or most likely cause. The regimens below are guideline examples, not self-treatment instructions:
- Bacterial vaginosis. CDC regimens include oral metronidazole, metronidazole vaginal gel, or clindamycin vaginal cream. The choice depends on pregnancy, tolerance, interactions, and the clinical setting (CDC BV guidance). The CDC notes that evidence does not support a disulfiram-like reaction between alcohol and metronidazole. Patients should still follow their prescriber’s advice and the product label.
- Yeast infection (candidiasis). Options may include a topical azole antifungal or, for selected nonpregnant patients, oral fluconazole. Pregnancy safety: During pregnancy, CDC guidance recommends only a 7-day course of topical azole therapy. Oral fluconazole should not be used (CDC candidiasis guidance). Treatment in pregnancy should be supervised by a clinician.
- Trichomoniasis. Oral nitroimidazole treatment is required, together with treatment of current partners. A clinician prescribes the exact regimen.
- Genitourinary syndrome of menopause. Vaginal moisturisers or local hormonal treatment may be considered after an individual assessment.
- Contact irritation. Stop the suspected irritant first. Persistent or severe symptoms need examination, because infection and skin conditions can look alike.
Impact on fertility, IVF, and pregnancy
An uncomplicated yeast infection is not known to damage the fallopian tubes. BV deserves clinical attention, particularly when it causes symptoms during pregnancy:
- During pregnancy. BV with symptoms is linked to problems including premature rupture of membranes and preterm birth. Pregnant women with symptoms should be assessed and treated (CDC BV guidance). The CDC does not recommend routine screening of pregnant women without symptoms, including those at higher risk of preterm birth, because trial results are mixed.
- During IVF and embryo transfer. Some observational studies (research that tracks outcomes without assigning a treatment) link a Lactobacillus-dominant vaginal microbiome with better IVF outcomes. They do not show that the vaginal profile causes implantation success. ESHRE does not recommend vaginal or uterine microbiome profiling after recurrent implantation failure.
- Upper genital tract health. Vaginal dysbiosis is different from chronic endometritis. A vaginal swab does not diagnose inflammation inside the uterus, so suspected chronic endometritis needs its own targeted assessment.
Practical daily care for vaginal health
Simple habits can reduce irritation without promising to “optimise” a microbiome result:
- Wash only the outer area (the vulva). Use warm water alone or a mild, unscented, soap-free cleanser (syndet). Never wash inside the vagina or spray water into it; the vagina cleans itself.
- Avoid vaginal douching. Douching is linked to BV and can raise the chance that BV comes back (CDC BV guidance). It is not a treatment for discharge or odour.
- Limit prolonged moisture and friction. Change out of damp clothing if it causes irritation. No special fabric guarantees protection from vaginitis.
- Use antibiotics only when prescribed. Antibiotics can change the vaginal flora, so they need a clear clinical reason.
Frequently Asked Questions for Dr. Aksoy
If a report says “shift in flora”, “altered flora” or “type 3 flora” but there are no symptoms, do you treat it?
A note of “flora change” on a vaginal swab does not necessarily mean an infection that needs treatment. I first look at what the report actually means. “Shift in flora” sometimes shows only that Lactobacillus has decreased and other bacteria have increased. “Type 3 flora”, however, can fit bacterial vaginosis in some grading systems, so the grading used and the woman’s clinical picture both matter.
In a woman who is not pregnant and has no itching, bad odour, abnormal discharge, or other complaint, I do not routinely start antibiotics for a flora change alone. Unnecessary antibiotics can disturb the vaginal balance further. Nor do I consider repeat testing necessary after every abnormal report when there are no symptoms.
Pregnancy, a planned gynaecological procedure, or another specific risk can change my assessment. What matters to me is not forcing the lab result back to normal, but finding out whether something really needs treatment.
If a report says “normal flora” but the itching and discharge continue, what do you do?
If itching, burning, or abnormal discharge continues, “normal flora” on a lab report does not mean the investigation is over for me. A standard vaginal culture cannot reveal every infection or every cause of vaginal discomfort.
I first ask how long the symptoms have lasted, which medicines have been used, which intimate hygiene products are in use, and whether symptoms follow the menstrual cycle. I then use examination, vaginal pH measurement, and microscopy to look for bacterial vaginosis, yeast infection, and, when needed, infections such as trichomoniasis. If recurrent yeast infection is suspected, identifying the Candida species can be important.
If all infection tests are normal, I consider non-infectious causes: contact dermatitis, irritation from products, hormonal changes, or skin conditions of the vulva. So I do not tell a patient “there is nothing wrong” just because the culture is normal. But I also do not advise repeated antibiotics or antifungals without knowing what is being treated. What matters is not the report but being able to explain the ongoing complaint.
If bacterial vaginosis keeps coming back, do you treat the partner too? When?
There has been an important change here in recent years. Treating the male partner for bacterial vaginosis used not to be generally recommended. An important randomised trial published in 2025 showed that treating the male partner with oral and topical antibiotics, at the same time as the woman, can clearly reduce the risk of recurrence.
So I now consider partner treatment especially for women with confirmed bacterial vaginosis, repeated symptoms despite appropriate treatment, and regular sex with the same partner. But I do not automatically give antibiotics to the partner of every woman who has a first episode or has no symptoms. I first want to be sure of the diagnosis, the treatments already used, and whether the recurrences are linked to sex.
If a partner is treated, the simultaneous oral and topical approach that worked in the research should be considered, rather than simply giving the man a single antibiotic dose. I also make a point of telling my patients that this does not necessarily mean infidelity or a new infection. Recurrent bacterial vaginosis does not mean poor hygiene either. The aim is to break the cycle of recurrence while avoiding unnecessary antibiotics.
More questions about vaginal flora and vaginitis
Can my symptoms alone tell me what is causing them?
No. Discharge, itching, burning, and odour overlap across BV, candidiasis, trichomoniasis, cervicitis, and non-infectious irritation. History, examination, and appropriate tests—sometimes including pH, microscopy, culture, or NAAT—help identify the cause.
Is bacterial vaginosis considered an STI?
Not in the same way as a classic STI. Bacterial vaginosis is a vaginal dysbiosis. Sexual activity and partner-related factors can still influence risk, and research on transmission is evolving. BV can also occur without recent sexual activity.
Can you have a yeast infection and bacterial vaginosis at the same time?
Yes. More than one condition can be present together. If symptoms persist after treatment, reassessment is more useful than assuming the first diagnosis covered everything.
Why do yeast infections often develop after taking antibiotics?
Antibiotics can alter bacterial communities that normally help keep Candida in balance. That can make candidiasis more likely in some people. Not every symptom after antibiotics is a yeast infection.
When should I consult a doctor rather than trying home remedies?
See a clinician if this is your first episode of vaginal symptoms, if you are pregnant, if you have lower abdominal or pelvic pain, if you develop a fever, or if symptoms keep returning or fail to clear within a few days of starting treatment.
Sources
- Centers for Disease Control and Prevention. Bacterial Vaginosis - STI Treatment Guidelines. MMWR Recomm Rep, 2021.
- Centers for Disease Control and Prevention. Vulvovaginal Candidiasis - STI Treatment Guidelines. MMWR Recomm Rep, 2021.
- Centers for Disease Control and Prevention. Trichomoniasis - STI Treatment Guidelines. MMWR Recomm Rep, 2021.
- Centers for Disease Control and Prevention. Vaginal Discharge - STI Treatment Guidelines. MMWR Recomm Rep, 2021.
- American College of Obstetricians and Gynecologists. Vaginitis in Nonpregnant Patients: ACOG Practice Bulletin No. 215. Obstet Gynecol, 2020;135(1):e1-e17. doi:10.1097/AOG.0000000000003604.
- American College of Obstetricians and Gynecologists. Concurrent Sexual Partner Therapy to Prevent Bacterial Vaginosis Recurrence. Obstet Gynecol, 2025;146(6):e111-e114. doi:10.1097/AOG.0000000000006102.
- Vieira-Baptista P, Stockdale CK, Sobel JD. Partner treatment in women with bacterial vaginosis: an update to the International Society for the Study of Vulvovaginal Disease (ISSVD) recommendations. Sex Transm Infect, 2026;102(3):195-197. doi:10.1136/sextrans-2025-056813.
- Aliyu Attahir Z, et al. Male Partner Treatment for Bacterial Vaginosis: A Systematic Review and Meta-Analysis of Randomized Trials. Sex Transm Dis, 2026;53(11):846-852. doi:10.1097/OLQ.0000000000002368.
- Gardella B, et al. Rethinking Prevention of Recurrent Bacterial Vaginosis: A Comparative Effectiveness Network Meta-Analysis. J Low Genit Tract Dis, 2026;30(4):325-340. doi:10.1097/LGT.0000000000000966.
- Liu D, Zhang X, Zhao X, Che X, Song W, Wu G. Bacterial vaginosis: advancing insights into microbial dysbiosis. Crit Rev Microbiol, 2026;52(1):159-175 (Epub 2025). doi:10.1080/1040841X.2025.2537923.
- Vodstrcil LA, et al. Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis. N Engl J Med, 2025;392(10):947-957. doi:10.1056/NEJMoa2405404.
- ESHRE Working Group on Recurrent Implantation Failure. ESHRE good practice recommendations on recurrent implantation failure. Hum Reprod Open, 2023;2023(3):hoad023.
- Powell AM. Overview of Vaginitis (Vulvovaginitis). MSD Manual Professional Edition, full review July 2026.
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.